MWG Management Ltd.

CIK 1845151 · View on SEC EDGAR ↗

Portfolio value: $81.3M
Positions: 3
As of: Sept. 30, 2025 Data as of Q3 2025

Portfolio value QoQ: +56.7% 13F does not disclose cash

Top 10 holdings weight: 100.00%
Top 25 holdings weight: 100.00%
Positions above 1%: 3
Effective number of positions: 1.9

Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)

Turnover Q3 2025: 13.38% Est. buys $16,371,804 · sells $8,911,745

Median holding: 3.5 quarters Tracked Q4 2024–Q3 2025 · 75.0% still held

New positions: 1
Increased: 0
Decreased: 0
Closed: 1

On this page

Sector breakdown How the portfolio splits across market sectors.
Portfolio Every stock this institution reports holding, from its latest 13F.
Biggest new bets Brand-new positions opened in the latest quarter.
Top moves The biggest position increases and decreases this quarter.
Exited positions Positions the manager fully sold out of last quarter.

Sector breakdown

Healthcare

100.0%

Full portfolio 3 positions

					Streak
BEAM Beam Therapeutics Inc. - Common Stock	$55,018,488	67.66%	2,266,934	$16,457,941
LYEL Lyell Immunopharma, Inc. - Common Stock	$16,371,804	20.13%	1,008,116		Up ×1
PRME Prime Medicine, Inc. - Common Stock	$9,928,843	12.21%	1,792,210	$5,502,084
No matches

Biggest new bets

New positions opened this quarter, largest first.

Security	Value	Shares	% of portfolio
LYEL	$16,371,804	1,008,116	20.13%

Top movers (QoQ)

Security	Action	Shares Δ	Value Δ
BEAM	Price move only	+0	+$16.5M
PRME	Price move only	+0	+$5.5M

Exited positions

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

Security	Quarter	Shares before	Value before	Price since exit
LYELXXXX	Sept. 30, 2025	1,008,116	$8,911,745	No longer tracked